Neurocrine Biosciences (NBIX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Neurocrine Biosciences (NBIX)

An SI Board Since July 1996

Posts	SubjectMarks	Bans	Symbol
1834	74	0	NBIX

Emcee: Billy Dunn	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1534	Neurocrine Biosciences Announces Positive Phase II Results With Its Orally Activ	LJM	-	4/27/2006
1533	probably not a bad idea at these prices, but I am holding on for the long haul.	mopgcw	-	4/25/2006
1532	I am now out 100%. The world of actual market penetration is just not for me.	keokalani'nui	-	4/25/2006
1531	Citi: NBIX: Not Asleep at the Wheel--Indiplon Approval appears On Track HOLD (	mopgcw	-	4/25/2006
1530	>>Ambien Patent Extension Seen Positive For Pfizer, Neurocrine Peter Kang,	tuck	-	4/10/2006
1529	Covered on Friday. Please take the pins out of my voodoo doll. TIA.	kenhott	-	4/10/2006
1528	Neurocrine Announces Peer-Reviewed Publication of Indiplon Mechanism of Action	Doc Bones	-	4/5/2006
1527	Pharmacopeia and Neurocrine Expand Drug Discovery and Development Collaboration	LJM	-	3/15/2006
1526	>> old geezers!! << Heh, heh.... be sure to wear a cup when and i	scaram(o)uche	-	3/8/2006
1525	5 or 6 years ago!!!! Well, he only beat me by 5 or 6 years. You bunch of old g	kenhott	-	3/8/2006
1524	Not mistaken. Rick called it. QED.	keokalani'nui	-	3/8/2006
1523	Ken--Perhaps I am mistaken--but I think Rick Harmon turned thumbs down on the AP	NeuroInvestment	-	3/8/2006
1522	<Rick Harmon called this a long time ago...> Didn't realize I was cha	kenhott	-	3/8/2006
1521	Rick Harmon called this a long time ago. Whether MS-APL was worth another PhII i	NeuroInvestment	-	3/8/2006
1520	These guys are the best in the biz at releasing bad news. Jon	Robohogs	-	3/8/2006
1519	Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Scler	Icebrg	-	3/8/2006
1518	John, PFE/NBIX move(s) forward depend on two major things: 1. How PFE see Indi	Miljenko Zuanic	-	3/7/2006
1517	No message. PFE's strategy already commented on munchabunch.	keokalani'nui	-	3/7/2006
1516	Thanks. Oh! OK, you mean more than $100 per share is triple digits. That'	John Metcalf	-	3/7/2006
1515	Triple digits--more than $100. Not percent, well, maybe Lyons would want 300%, b	NeuroInvestment	-	3/6/2006
1514	"Pfizer--and that's the only company Lyons believes would make sense, g	John Metcalf	-	3/6/2006
1513	We know it took GSK three or four years, and at least three iterations of the pl	NeuroInvestment	-	3/6/2006
1512	"I don't think near term share price weakness would make much differenc	John Metcalf	-	3/6/2006
1511	On the FWIW front. Yesterday I sold 40% of my remaining NBIX holdings at the $7	Biotech Jim	-	3/4/2006
1510	One way to look at it is that indiplon WILL do $1-1.5 B globally, no questions a	Robohogs	-	3/3/2006

Go to reply# or date (mm/dd/yy):